Where does Envisagenics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Envisagenics's 2 recorded funding rounds.

Premier Alternatives

Envisagenics

Long Island City, NY · Founded 2014 · Privately Held (backing)

Developer of a bioinformatics platform designed to accelerate the development of novel therapeutics. Envisagenics is based in Long Island City, NY and was founded in 2014. Its last known valuation is $150 million. It has raised $40.5 million across 2 recorded rounds; the latest was a $19.2 million early-stage round in Sep 2021.

Last price · $/share

—

Implied valuation

$150.0M

Total raised

$40.5M

Last round

Early Stage VC

Sep 2021

Cap table — not yet on record

Envisagenics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Envisagenics with a free account

·The complete investor list: 24 names
·Watch Envisagenics: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Envisagenics

Where does Envisagenics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Envisagenics's 2 recorded funding rounds.